Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL866 (68618, Mycophenolate, Mycophenolate mofetil impurity, mycophenolic acid-, Mycophenolic acid, Myfortic, NSC-129185, RS-61443 [AS MOFETIL]) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
Inosine-5`-monophosphate dehydrogenase in Cryptococcus neoformans var. neoformans serotype D (strain JEC21 /ATCC MYA-565) (Filobasidiella neoformans) (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4295605] [UniProtKB: Q5KP44] | ||||||||
ChEMBL | Inhibition of recombinant Cryptococcus neoformans His-tagged IMPDH expressed in Escherichia coli BL21 (DE3) using IMP as substrate in presence of NAD | B | 6.92 | pIC50 | 120 | nM | IC50 | Bioorg Med Chem (2018) 26: 5408-5419 [PMID:30322754] |
inosine monophosphate dehydrogenase 1/Inosine-5`-monophosphate dehydrogenase 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1822] [GtoPdb: 2624] [UniProtKB: P20839] | ||||||||
ChEMBL | Inhibition of human IMPDH 1 | B | 7.4 | pKi | 40 | nM | Ki | J Med Chem (2007) 50: 6685-6691 [PMID:18038969] |
ChEMBL | Inhibitory activity against human Inosine-5'-monophosphate dehydrogenase 1 (IMPDH type I) | B | 7.4 | pKi | 40 | nM | Ki | J Med Chem (2002) 45: 703-712 [PMID:11806722] |
ChEMBL | Inhibition of human IMPDH1 | B | 7.4 | pKi | 40 | nM | Ki | Bioorg Med Chem (2008) 16: 9340-9345 [PMID:18809333] |
ChEMBL | Inhibition of human IMP dehydrogenase 1 | B | 7.4 | pKi | 40 | nM | Ki | Bioorg Med Chem (2008) 16: 7462-7469 [PMID:18583139] |
ChEMBL | Inhibitory activity against human Inosine-5'-monophosphate dehydrogenase 1 (IMPDH type I isoform); Range is 33-37 nM | B | 7.48 | pKi | 33 | nM | Ki | J Med Chem (1998) 41: 618-622 [PMID:9484510] |
ChEMBL | Inhibition of human IMPDH type 1 | B | 7.48 | pKi | 33 | nM | Ki | J Med Chem (2007) 50: 5743-5751 [PMID:17958343] |
ChEMBL | Inhibition of human IMPDH1 by Spectrophotometry | B | 7.48 | pKi | 33 | nM | Ki | Bioorg Med Chem (2011) 19: 1594-1605 [PMID:21324702] |
ChEMBL | Inhibition of recombinant human His-tagged IMPDH1 expressed in Escherichia coli BL21 (DE3) using IMP as substrate in presence of NAD | B | 6.59 | pIC50 | 260 | nM | IC50 | Bioorg Med Chem (2018) 26: 5408-5419 [PMID:30322754] |
ChEMBL | Inhibitory activity against inosine monophosphate dehydrogenase IMPDH type I | B | 7.26 | pIC50 | 55 | nM | IC50 | Bioorg Med Chem Lett (2003) 13: 543-546 [PMID:12565968] |
ChEMBL | Inhibition of human IMPDH1 | B | 7.49 | pIC50 | 32 | nM | IC50 | Bioorg Med Chem Lett (2006) 16: 3479-3483 [PMID:16621550] |
ChEMBL | In vitro inhibition of inosine Inosine-5'-monophosphate dehydrogenase | B | 7.7 | pIC50 | 20 | nM | IC50 | J Med Chem (1990) 33: 833-838 [PMID:1967654] |
GtoPdb | Reference does not distinguish which enzyme isoform is assayed | - | 7.7 | pIC50 | 20 | nM | IC50 | J Med Chem (1990) 33: 833-8 [PMID:1967654] |
ChEMBL | Inhibition of human IMPDH1 expressed in Escherichia coli strain BL21(DE3) after 60 mins | B | 7.72 | pIC50 | 19 | nM | IC50 | Bioorg Med Chem (2010) 18: 8106-8111 [PMID:20934342] |
inosine monophosphate dehydrogenase 2/Inosine-5`-monophosphate dehydrogenase 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2002] [GtoPdb: 2625] [UniProtKB: P12268] | ||||||||
ChEMBL | Inhibition of human IMPDH 2 | B | 8 | pKi | 10 | nM | Ki | J Med Chem (2007) 50: 6685-6691 [PMID:18038969] |
ChEMBL | Inhibitory activity against human Inosine-5'-monophosphate dehydrogenase 2 (IMPDH type II) | B | 8 | pKi | 10 | nM | Ki | J Med Chem (2002) 45: 703-712 [PMID:11806722] |
ChEMBL | Inhibition of human IMPDH2 | B | 8 | pKi | 10 | nM | Ki | Bioorg Med Chem (2008) 16: 9340-9345 [PMID:18809333] |
ChEMBL | Inhibition of human IMP dehydrogenase 2 | B | 8 | pKi | 10 | nM | Ki | Bioorg Med Chem (2008) 16: 7462-7469 [PMID:18583139] |
ChEMBL | Inhibition of human IMPDH type 2 | B | 8.15 | pKi | 7 | nM | Ki | J Med Chem (2007) 50: 5743-5751 [PMID:17958343] |
ChEMBL | Inhibition of human IMPDH2 by Spectrophotometer | B | 8.15 | pKi | 7 | nM | Ki | Bioorg Med Chem (2011) 19: 1594-1605 [PMID:21324702] |
ChEMBL | Inhibitory activity against human Inosine-5'-monophosphate dehydrogenase 2 (IMPDH type II isoform); Range is 6-10 nM | B | 8.22 | pKi | 6 | nM | Ki | J Med Chem (1998) 41: 618-622 [PMID:9484510] |
ChEMBL | Inhibition of IMPDH2 | B | 5.82 | pIC50 | 1500 | nM | IC50 | Bioorg Med Chem Lett (2012) 22: 53-56 [PMID:22172700] |
ChEMBL | Inhibition of IMPDH2 using inosine 5'-monophosphate as substrate by spectrophotometry | B | 6.2 | pIC50 | 630 | nM | IC50 | Bioorg Med Chem Lett (2012) 22: 3332-3335 [PMID:22464133] |
ChEMBL | Inhibition of human IMPDH2 using IMP as substrate in presence of NAD+ after 30 mins | B | 6.6 | pIC50 | 250 | nM | IC50 | Eur J Med Chem (2018) 158: 286-301 [PMID:30223117] |
ChEMBL | Inhibition of recombinant human His-tagged IMPDH2 expressed in Escherichia coli BL21 (DE3) using IMP as substrate in presence of NAD | B | 6.96 | pIC50 | 110 | nM | IC50 | Bioorg Med Chem (2018) 26: 5408-5419 [PMID:30322754] |
ChEMBL | Compound was tested for inhibition of human recombinant type II Inosine Monophosphate Dehydrogenase at pH 7.4 | B | 7.6 | pIC50 | 25.1 | nM | IC50 | J Med Chem (1996) 39: 4181-4196 [PMID:8863796] |
ChEMBL | Compound was tested for inhibition of human recombinant type II Inosine Monophosphate Dehydrogenase at pH 8.0 | B | 7.61 | pIC50 | 24.8 | nM | IC50 | J Med Chem (1996) 39: 4181-4196 [PMID:8863796] |
GtoPdb | Reference does not distinguish which enzyme isoform is assayed | - | 7.7 | pIC50 | 20 | nM | IC50 | J Med Chem (1990) 33: 833-8 [PMID:1967654] |
ChEMBL | Inhibition of human IMPDH2 | B | 7.8 | pIC50 | 16 | nM | IC50 | J Med Chem (2007) 50: 3730-3742 [PMID:17585753] |
ChEMBL | In vitro inhibition of Inosine-5'-monophosphate dehydrogenase 2. | B | 7.82 | pIC50 | 15 | nM | IC50 | Bioorg Med Chem Lett (2002) 12: 2931-2934 [PMID:12270177] |
ChEMBL | Inhibition of Inosine Monophosphate Dehydrogenase II (IMPDH II) | B | 7.82 | pIC50 | 15 | nM | IC50 | Bioorg Med Chem Lett (2002) 12: 3125-3128 [PMID:12372516] |
ChEMBL | Inhibitory activity tested against inosine-5'-monophosphate dehydrogenase 2 (IMPDH-II) enzyme | B | 7.82 | pIC50 | 15 | nM | IC50 | Bioorg Med Chem Lett (2003) 13: 3557-3560 [PMID:14505670] |
ChEMBL | Inhibitory concentration against Inosine-5'-monophosphate dehydrogenase 2 was determined | B | 7.82 | pIC50 | 15 | nM | IC50 | Bioorg Med Chem Lett (2002) 12: 3305-3308 [PMID:12392738] |
ChEMBL | Inhibition of human Inosine-5'-monophosphate dehydrogenase 2 | B | 7.82 | pIC50 | 15 | nM | IC50 | Bioorg Med Chem Lett (2002) 12: 2137-2140 [PMID:12127522] |
ChEMBL | Inhibition of human inosine monophosphate dehydrogenase IMPDH II | B | 7.85 | pIC50 | 14 | nM | IC50 | Bioorg Med Chem Lett (2003) 13: 543-546 [PMID:12565968] |
ChEMBL | Inhibitory activity against inosine monophosphate dehydrogenase IMPDH II | B | 7.85 | pIC50 | 14 | nM | IC50 | Bioorg Med Chem Lett (2003) 13: 547-551 [PMID:12565969] |
ChEMBL | Inhibition of human inosine-5'-monophosphate dehydrogenase 2 | B | 7.85 | pIC50 | 14 | nM | IC50 | J Med Chem (2002) 45: 2127-2130 [PMID:12014950] |
ChEMBL | Inhibition of human IMPDH2 expressed in Escherichia coli strain BL21(DE3) after 60 mins | B | 7.92 | pIC50 | 12 | nM | IC50 | Bioorg Med Chem (2010) 18: 8106-8111 [PMID:20934342] |
ChEMBL | Inhibition of human IMPDH2 | B | 7.96 | pIC50 | 11 | nM | IC50 | Bioorg Med Chem Lett (2006) 16: 3479-3483 [PMID:16621550] |
Plasmodium berghei (target type: ORGANISM) [ChEMBL: CHEMBL612653] | ||||||||
ChEMBL | HARVARD: Inhibition of liver stage Plasmodium berghei infection in HepG2 cells | F | 6 | pIC50 | 1000 | nM | IC50 | Proc Natl Acad Sci U S A (2012) 109: 8511-8516 [PMID:22586124] |
Plasmodium falciparum (target type: ORGANISM) [ChEMBL: CHEMBL364] | ||||||||
ChEMBL | HARVARD: Inhibition of blood stage Plasmodium falciparum Dd2 infection | F | 5.3 | pIC50 | >5000 | nM | IC50 | Proc Natl Acad Sci U S A (2012) 109: 8511-8516 [PMID:22586124] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]